ASX:SRX

Sirtex Medical Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend Yield0.89%
BetaN/A

Receive SRX News and Ratings via Email

Sign-up to receive the latest news and ratings for Sirtex Medical and its competitors with MarketBeat's FREE daily newsletter.


Sirtex Medical logo

About Sirtex Medical

Sirtex Medical Limited, a life-sciences company, develops and delivers oncology treatments using novel small particle technology in the Asia-Pacific, Europe, the Middle East, Africa, and North and South America. The company's principal product is the SIR-Spheres Y-90 resin microspheres, a targeted radioactive treatment for primary and secondary metastatic liver cancer. Sirtex Medical Limited is headquartered in North Sydney, Australia.

Headlines

Carcinoid Syndrome Management Market by Trends, Growth, Scope, Size, Overall Analysis and Prognostication
Carcinoid Syndrome Management Market by Trends, Growth, Scope, Size, Overall Analysis and Prognostication
January 12, 2021 |  marketwatch.com
Embolotherapy Market Is Projected To Reach USD 4.9 Billion By 2024 From USD 3.3 Billion In 2019, At A CAGR Of 8.1%
Embolotherapy Market Is Projected To Reach USD 4.9 Billion By 2024 From USD 3.3 Billion In 2019, At A CAGR Of 8.1%
January 4, 2021 |  marketwatch.com
Transcatheter Embolization and Occlusion Devices Market Research with Size, Growth, Manufacturers, Segments and 2026 Forecasts Research
Transcatheter Embolization and Occlusion Devices Market Research with Size, Growth, Manufacturers, Segments and 2026 Forecasts Research
January 4, 2021 |  marketwatch.com
Transcatheter Embolization and Occlusion Devices Market 2020 Current and Future Trend Scenario Explored In New Latest Research Report
Transcatheter Embolization and Occlusion Devices Market 2020 Current and Future Trend Scenario Explored In New Latest Research Report
December 18, 2020 |  marketwatch.com
Microspheres Market Report 2020, Global Industry Trends, Share, Size, Growth & Forecast to 2025
Microspheres Market Report 2020, Global Industry Trends, Share, Size, Growth & Forecast to 2025
December 1, 2020 |  marketwatch.com
Sirtex Medical and China Grand Pharmaceutical announce SIR-Spheres Y-90 resin microspheres milestone
Sirtex Medical and China Grand Pharmaceutical announce SIR-Spheres Y-90 resin microspheres milestone
November 27, 2020 |  finanznachrichten.de
Sirtex Medical and China Grand Pharmaceutical announce SIR-Spheres® Y-90 resin microspheres milestone
Sirtex Medical and China Grand Pharmaceutical announce SIR-Spheres® Y-90 resin microspheres milestone
November 25, 2020 |  markets.businessinsider.com
Transcatheter Embolization and Occlusion Devices Market Research Report Covers, Future Trends, Past, Present Data and Deep Analysis [2020-2025]
Transcatheter Embolization and Occlusion Devices Market Research Report Covers, Future Trends, Past, Present Data and Deep Analysis [2020-2025]
November 19, 2020 |  marketwatch.com
Varian Medical Systems, Inc.
Varian Medical Systems, Inc.
August 14, 2020 |  uk.reuters.com
ScoPo’s health powerplays: The transition to greatest
ScoPo’s health powerplays: The transition to greatest
May 22, 2020 |  www.msn.com
See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank™

Overall MarketRank™

0.80 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Sirtex Medical (ASX:SRX) Frequently Asked Questions

What stocks does MarketBeat like better than Sirtex Medical?

Wall Street analysts have given Sirtex Medical a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Sirtex Medical wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How were Sirtex Medical's earnings last quarter?

Sirtex Medical Limited (ASX:SRX) announced its earnings results on Wednesday, August, 29th. The medical device company reported $0.74 earnings per share for the quarter, missing the Zacks' consensus estimate of $0.97 by $0.23.
View Sirtex Medical's earnings history.

Who are Sirtex Medical's key executives?

Sirtex Medical's management team includes the following people:
  • Mr. Andrew McLean, CEO, MD Exec. Director
  • Mr. Darren Smith M.B.A., B.Bus., FCPA, CFO & Company Sec. (Age 53)
  • Mr. Anthony Dixon, Exec. VP of Sales & Marketing - EMEA
  • Mr. G. Spindler, Global Head of Operations
  • Dr. Thomas Duthy, Global Head of Investor Relations & Corp. Devel.

Who are some of Sirtex Medical's key competitors?

Some companies that are related to Sirtex Medical include (CHV) (CHV), (DDXS) (DDXS), (PREV) (PREV), (TNGN) (TNGN), 45525 (CUR.TO) (CUR), Abattis Bioceuticals (ATTBF), Abzena (ABZA), Acrux (ACR), Actinogen Medical (ACW), AdAlta (1AD), Admedus (AHZ), Algernon Pharmaceuticals (AGNPF), Almirall (LBTSF), Amarantus BioScience (AMBS) and Amplia Therapeutics (ATX).
View all of SRX's competitors.

What other stocks do shareholders of Sirtex Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sirtex Medical investors own include Capricorn Metals (CMM), Woodside Petroleum (WPL), Bristol-Myers Squibb (BMY), REA Group (REA), Woodside Petroleum (WOPEY), Cardinal Health (CAH), BTG (BTG), Boston Scientific (BSX), Blackmores (BKL) and BHP Group (BHP).

What is Sirtex Medical's stock symbol?

Sirtex Medical trades on the ASX under the ticker symbol "SRX."

What is Sirtex Medical's official website?

The official website for Sirtex Medical is www.sirtex.com.

Where are Sirtex Medical's headquarters?

Sirtex Medical is headquartered at L 33 101 Miller St, NORTH SYDNEY, NSW 2060, Australia.

How can I contact Sirtex Medical?

Sirtex Medical's mailing address is L 33 101 Miller St, NORTH SYDNEY, NSW 2060, Australia. The medical device company can be reached via phone at +61-2-99648400.


This page was last updated on 8/5/2021 by MarketBeat.com Staff

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.